Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 2
×
Mesothelioma, Malignant
×
Ipilimumab
×
Clear all
Filters
3
NCT05136677
2026-01-23
CheckMate 6DW
Bristol-Myers Squibb
Phase 2
Completed
102 enrolled
NCT04300244
2024-02-29
NIPU
Oslo University Hospital
Phase 2
Active not recruiting
118 enrolled
NCT03048474
2021-01-20
INITIATE
The Netherlands Cancer Institute
Phase 2
Completed
36 enrolled